{
  "ptid_time": "021_S_4744_2012-05-31",
  "img_path": "/data/qiuhui/data/adni/images/021_S_4744/2012-05-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 12,000 mm³, 57.2% below the reference mean. With a Z-score of -1.31 (9.5th percentile), this represents mild atrophy; hippocampal volume measures 7,408 mm³, 4.1% above the reference mean. With a Z-score of 0.38 (64.7th percentile), this represents normal volume ; whole brain volume measures 920,454 mm³, 5.6% below the reference mean. With a Z-score of -0.70 (24.2th percentile), this represents normal volume . ",
  "text_data": "Age is 72.3 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 24.0. MoCA: 21.0. Logical Memory: 6.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.23 SUVR (mild elevated); Amyloid beta: 617.80 pg/mL (mild reduced); Total tau: 551.60 pg/mL (profound elevated); Phosphorylated tau: 57.71 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows mild ventricular atrophy but normal hippocampal and whole brain volumes. Cognitive testing (MMSE 24, MoCA 21) suggests mild impairment, while CSF biomarkers (elevated T-tau, P-tau, and mildly reduced Aβ) are consistent with Alzheimer’s pathology. The presence of two APOE4 alleles further increases AD risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Note: The cognitive scores fall in the MCI range, and biomarker evidence strongly supports underlying AD pathology. However, functional independence is implied since dementia is not diagnosed—this would require greater cognitive and daily living impairment.)*",
  "timestamp": "2025-07-26T01:50:59.619221"
}